NCT02599038View on ClinicalTrials.gov

Serine Supplementation for Obese Subjects With Fatty Liver Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Serine supplementation

Serine supplementation (200 mg/kg/day)

Trial Locations (2)

411 31

Hanns-Ulrich Marschall, Gothenburg

Unknown

Sahlgrenska Academy, Gothenburg

All Listed Sponsors
lead

Hanns-Ulrich Marschall

OTHER

NCT02599038 - Serine Supplementation for Obese Subjects With Fatty Liver Disease | Biotech Hunter | Biotech Hunter